A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients (ALECSAT-GBM)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
CytoVac A/S
ClinicalTrials.gov Identifier:
NCT01588769
First received: April 27, 2012
Last updated: April 4, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2013
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)